Author

Manuel Barreiro-de Acosta 1

1 University Hospital of Santiago,Gastroenterology,Santiago de Compostela,Spain

ARE TROUGH LEVELS OF ANTI-TNF DRUGS RELATED WITH TREATMENT FAILURE AND DURATION OF TREATMENT?

Jaime González-López, Manuel Barreiro-de Acosta, Carmen Llamas, Juan Enrique Dominguez-Munoz, José María Giráldez-Montero, Rocio Ferreiro Iglesias, María Jesús Lamas-Díaz

CLINICAL CHARACTERISTICS AND MANAGEMENT OF CROHN'S DISEASE IN PATIENTS WITH RESIDUAL DISEASE AFTER SURGERY COMPARED WITH CURATIVE SURGERY. RESULTS FROM PRACTICROHN STUDY.

Eugeni Domenech Morral, Maria Dolores Martín Arranz, Ana Gutierrez Casbas, Marisa Iborra, Valle García-Sánchez, Manuel Barreiro-de Acosta, Luis Cea-Calvo, Cristina Romero, Berta Juliá De Páramo

COMPARISON OF THE EFFICACY OF A SECOND INTRAVENOUS OR SUBCUTANEOUS ANTI-TNF IN THE TREATMENT OF ULCERATIVE COLITIS. REAL-WORLD DATA FROM THE ENEIDA REGISTRY

Paola Francesca Torres Rodríguez, Fiorella Cañete Pizarro, Margalida Calafat Sard, Joan Toscá Cuquerella, Ruben Sanchez-Aldehuelo, Montserrat Rivero Tirado, Marisa Iborra, Maria González Vivo, Maria Isabel Vera, Luisa de Castro, Luis Bujanda, Manuel Barreiro-de Acosta, Carlos González-Muñosa, Xavier Calvet, Jose Manuel Benite

Differences in immune cell population subsets in inflammatory bowel disease patients under anti-TNF treatment and healthy controls

Manuel Barreiro-de Acosta, Sara Notarariego, Juan E. Viñuela-Roldan, Pablo Romero, Adriano Quiroga-Castiñeira, Juan Enrique Dominguez-Munoz

Efficacy, safety and cost-efficiency of adalimumab 80 mg every other week in previously intensified patients on adalimumab 40 mg every week

Manuel Barreiro-de Acosta, Rocio Ferreiro Iglesias, Andrea Jardi-Cuadrado, Adriano Quiroga-Castiñeira, Iria Baston-Rey, Jaime González, Ana Sousa, Irene Zarra, Juan Enrique Dominguez-Munoz

EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE IN SPAIN: INTERIM ANALYSIS OF THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Jose Luis Cabriada, María José Casanova, D Ceballos, M Esteve, Hipolito Fernández Rosáenz, Manuel Barreiro-de Acosta, Valle García-Sánchez, Daniel Ginard Vicens, Fernando Gomollón, Rufo Lorente Poyatos, Pilar Nos Mateu, Sabino Riestra Menéndez, Montserrat Rivero Tirado, Pilar Robledo Andrés, Cristina

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, JOSE MANUEL BENITEZ CANTERO, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollon, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emi

FEAR OF COVID-19 AMONG PERSONS WITH IBD ACCORDING TO EMPLOYMENT STATUS, EDUCATIONAL BACKGROUND AND RESIDENTIAL SETTING, AS COMPARED TO PERSONS WITH OTHER GASTROINTESTINAL CONDITIONS

Manuel Barreiro-de Acosta, Charles N. Bernstein, Nuno Ferreira, Richard B. Gearry, Antonina Mikocka-Walus, Inês Trindade, Simon Knowles, Bobby Lo, Johan Burisch, Anne Mokrowiecka

FEMALE GENDER INCREASES THE RISK OF ANXIETY AND DEPRESSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER ANTI-TNFα THERAPY

Rocío Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Cristina Calviño-Suárez, Iria Baston Rey, Juan Enrique Dominguez-Munoz

LONG-TERM OUTCOMES OF BIOLOGIC THERAPY IN CROHN’S DISEASE COMPLICATED WITH INTERNAL FISTULIZING DISEASE: BIOSCOPE STUDY FROM GETECCU

Iago Rodríguez-Lago, Francisco Mesonero, Fransisco Javier García-Alonso, Luisa de Castro, Beatriz Sicilia, Irene Gonzalez Partida, Leyanira Torrealba, Ainara Elorza, Elena Betoré, Fiorella Cañete, Xavier Calvet Calvo, Rocío Ferreiro-Iglesias, Sabino Riestra Menéndez, Pilar Varela Trastoy, Beatriz Castro Senosiain, Ana Gutier

Item 1 - 10 / 13
1
2